Zobrazeno 1 - 10
of 10
pro vyhledávání: '"María Paula Roberti"'
Autor:
Yamila Sol Rocca, María Paula Roberti, Estefanía Paula Juliá, María Betina Pampena, Luisina Bruno, Sergio Rivero, Eduardo Huertas, Fernando Sánchez Loria, Alejandro Pairola, Anne Caignard, José Mordoh, Estrella Mariel Levy
Publikováno v:
Frontiers in Immunology, Vol 7 (2016)
The clinical outcome of colorectal cancer (CRC) is associated with the immune response, thus these tumors could be responsive to different immune therapy approaches. NK cells are key anti-tumor primary effectors that can eliminate CRC cells without p
Externí odkaz:
https://doaj.org/article/fcdd73a7e1414aee999e29a609fdc510
Publikováno v:
Frontiers in Immunology, Vol 3 (2012)
In recent decades, tumor surveillance by the immune system and its impact on disease outcomes in cancer patients in general and in breast cancer (BC) patients in particular has been documented. Natural killer (NK) cells are central components of the
Externí odkaz:
https://doaj.org/article/c42f8db8e4c14ed9b7be1b85bd437325
Autor:
María Marcela Barrio, Riad Abes, Marina Colombo, Gabriela Pizzurro, Charlotte Boix, María Paula Roberti, Emmanuelle Gélizé, Mariana Rodriguez-Zubieta, José Mordoh, Jean-Luc Teillaud
Publikováno v:
PLoS ONE, Vol 7, Iss 7, p e40311 (2012)
Dendritic cells (DC) can achieve cross-presentation of naturally-occurring tumor-associated antigens after phagocytosis and processing of dying tumor cells. They have been used in different clinical settings to vaccinate cancer patients. We have prev
Externí odkaz:
https://doaj.org/article/6063186d4c954a6191316ff2f4298ff8
Autor:
Marten Meyer, Christina Parpoulas, Titouan Barthélémy, Jonas P. Becker, Pornpimol Charoentong, Yanhong Lyu, Selina Börsig, Nadja Bulbuc, Claudia Tessmer, Lisa Weinacht, David Ibberson, Patrick Schmidt, Rüdiger Pipkorn, Stefan B. Eichmüller, Peter Steinberger, Katharina Lindner, Isabel Poschke, Michael Platten, Stefan Fröhling, Angelika B. Riemer, Jessica C. Hassel, Maria Paula Roberti, Dirk Jäger, Inka Zörnig, Frank Momburg
Publikováno v:
Frontiers in Immunology, Vol 14 (2024)
Peptide-loaded MHC class I (pMHC-I) multimers have revolutionized our capabilities to monitor disease-associated T cell responses with high sensitivity and specificity. To improve the discovery of T cell receptors (TCR) targeting neoantigens of indiv
Externí odkaz:
https://doaj.org/article/2562f0907ae7489481331f6d349419cb
Autor:
Estrella Mariel Levy, María Paula Roberti, Luis A. Quesada-Allué, Jean-Luc Teillaud, Gabriela Andrea Pizzurro, Florencia Paula Madorsky Rowdo, Luciana M. Pujol-Lereis, Andrea M. Copati, Maria Marcela Barrio, José Mordoh
Gamma irradiation is one of the methods used to sterilize melanoma cells prior to coculturing them with monocyte-derived immature dendritic cells in order to develop antitumor vaccines. However, the changes taking place in tumor cells after irradiati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::161f9b23ef26fbac877e53a18d42cdf3
http://link.springer.com/article/10.1007/s00262-012-1295-4
http://link.springer.com/article/10.1007/s00262-012-1295-4
Autor:
Jean-Luc Teillaud, Mariana Rodriguez-Zubieta, Marina Colombo, Gabriela Andrea Pizzurro, Riad Abès, Maria Marcela Barrio, Charlotte Boix, José Mordoh, María Paula Roberti, Emmanuelle Gélizé
Publikováno v:
PLoS ONE, Vol 7, Iss 7, p e40311 (2012)
PLoS ONE
PLoS ONE
Dendritic cells (DC) can achieve cross-presentation of naturally-occurring tumor-associated antigens after phagocytosis and processing of dying tumor cells. They have been used in different clinical settings to vaccinate cancer patients. We have prev
Autor:
Marine Fidelle, Satoru Yonekura, Marion Picard, Alexandria Cogdill, Antoine Hollebecque, Maria Paula Roberti, Laurence Zitvogel
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
While colorectal cancers (CRC) are paradigmatic tumors invaded by effector memory lymphocytes, the mechanisms accounting for the relative resistance of MSI negative CRC to immunogenic cell death mediated by oxaliplatin and immune checkpoint inhibitor
Externí odkaz:
https://doaj.org/article/f1051ce6705545ee9fae6da622db0233
Autor:
Romain Daillère, Bertrand Routy, Anne-Gaëlle Goubet, Alexandria Cogdill, Gladys Ferrere, Carolina Alves-Costa Silva, Aurélie Fluckiger, Pierre Ly, Yacine Haddad, Eugenie Pizzato, Cassandra Thelemaque, Marine Fidelle, Marine Mazzenga, Maria Paula Roberti, Cléa Melenotte, Peng Liu, Safae Terrisse, Oliver Kepp, Guido Kroemer, Laurence Zitvogel, Lisa Derosa
Publikováno v:
OncoImmunology, Vol 9, Iss 1 (2020)
Accumulating evidence from preclinical studies and human trials demonstrated the crucial role of the gut microbiota in determining the effectiveness of anticancer therapeutics such as immunogenic chemotherapy or immune checkpoint blockade. In summary
Externí odkaz:
https://doaj.org/article/7883c109e64b47148bb219b834aa95a9
Publikováno v:
OncoImmunology, Vol 9, Iss 1 (2020)
Why PD-1 blockade is ineffective in the vast majority of colorectal cancers (CCs) lacking microsatellite instability but harboring high densities of tumor infiltrating T cells and follicular T helper (TFH) and B cells remained so far an open conundru
Externí odkaz:
https://doaj.org/article/ffab78885c61471db2d5cb0b9a0962c0
Autor:
Nicolas Jacquelot, Jonathan M. Pitt, David P. Enot, Maria Paula Roberti, Connie P. M. Duong, Sylvie Rusakiewicz, Alexander M. Eggermont, Laurence Zitvogel
Publikováno v:
OncoImmunology, Vol 6, Iss 8 (2017)
Existing clinical, anatomopathological and molecular biomarkers fail to reliably predict the prognosis of cutaneous melanoma. Biomarkers for determining which patients receive adjuvant therapies are needed. The emergence of new technologies and the d
Externí odkaz:
https://doaj.org/article/c79e6bff49d74b6fbe3298685cce8dde